Bio-Path Holdings Files 8-K on Operations and Financials
Ticker: BPTH · Form: 8-K · Filed: May 15, 2024 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | May 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, sec-filing
Related Tickers: BPTH
TL;DR
BPTH filed an 8-K updating financials - check for details.
AI Summary
Bio-Path Holdings, Inc. filed an 8-K on May 15, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates Bio-Path Holdings is providing updates on its financial status and operational results to the SEC, which is important for investors to monitor the company's performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting operational and financial information, not indicating any immediate or significant new risks.
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- 0001544784-24-000068 (filing_id) — Accession Number
- May 15, 2024 (date) — Report Date
- Delaware (jurisdiction) — State of Incorporation
- 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401 (address) — Principal Executive Office Address
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text of the 8-K filing for Bio-Path Holdings, Inc. on May 15, 2024, indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but it does not include the specific financial figures or operational details within this excerpt.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported in this 8-K filing is May 15, 2024.
What is the Commission File Number for Bio-Path Holdings, Inc.?
The Commission File Number for Bio-Path Holdings, Inc. is 001-36333.
In which state is Bio-Path Holdings, Inc. incorporated?
Bio-Path Holdings, Inc. is incorporated in Delaware.
What is the business address of Bio-Path Holdings, Inc. as listed in the filing?
The business address of Bio-Path Holdings, Inc. is 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401.
Filing Stats: 550 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-05-15 07:10:29
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M
Filing Documents
- bpth-20240515x8k.htm (8-K) — 39KB
- bpth-20240515xex99d1.htm (EX-99.1) — 30KB
- bpth-20240515xex99d1001.jpg (GRAPHIC) — 11KB
- 0001544784-24-000068.txt ( ) — 208KB
- bpth-20240515.xsd (EX-101.SCH) — 3KB
- bpth-20240515_lab.xml (EX-101.LAB) — 16KB
- bpth-20240515_pre.xml (EX-101.PRE) — 10KB
- bpth-20240515x8k_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. The information in this Current Report on Form 8-K (this "Current Report") is being furnished pursuant to Item 2.02 of Form 8-K and, according to general instruction B.2. thereunder, the information in this Current Report shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended. On May 15, 2024, Bio-Path Holdings, Inc. (the "Company") issued a press release announcing financial results for the quarter ended March 31, 2024. Additional information is included in the Company's press release. A copy of the Company's press release is attached hereto as Exhibit 99.1. The foregoing description of the press release is qualified in its entirety by reference to the attached exhibit.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press release dated May 15, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: May 15, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer